Dr. Olivia Martinez received her Ph.D. in Immunology from UC Berkeley and completed post-doctoral fellowships in Immunology and Transplant Immunology at UC Berkeley and UCSF, respectively. Dr. Martinez joined the faculty at Stanford University School of Medicine in 1995 and is currently Professor of Surgery and Director of the PhD Program in Immunology. Dr. Martinez has been a member of numerous NIH advisory committees, including the Immunobiology Study Section, the Surgery, Anesthesia, and Trauma Study Section, and the Transplant, Tolerance and Tumor Immunology Study Section. Dr. Martinez is an Associate Editor of Transplantation and BMC Immunology. She also serves on the editorial boards of Pediatric Transplantation and Digestive Diseases and Sciences. Dr. Martinez was the organizer and Co-Chair of the Sixth Basic Sciences Symposium of The Transplantation Society. She has been an active member of the American Association of Immunologists where she served on numerous committees and was Director of the AAI Course in Advanced Immunology. She has also been an active member of the American Society of Transplantation and served as Chair of the Basic Science Committee. Dr. Martinez has received several prestigious awards including the Fujisawa Basic Science Award in Transplantation, the American Association of Immunologists Distinguished Service Award, the Stanford Office of Graduate Education Faculty Award for Student Service, and the Stanford Biosciences Faculty Award for Excellence in Mentoring. Research in Dr. Martinez’ laboratory focuses on 1) understanding mechanisms of rejection and tolerance in solid organ and stem-cell transplantation 2) utilizing stem cell-based approaches for treatment of liver disease and 3) understanding the pathogenesis of Epstein Barr virus B cell lymphomas with the goal of improving diagnosis and treatment of post-transplant lymphomas. Dr. Martinez is author of over 100 original research publications, review articles, book chapters and conference proceedings. Her laboratory has been funded by the NIH for over 20 years and has also been supported by the Roche Organ Transplant Research Foundation and the Department of Defense.
14:45 - 16:15
|State-of-the-Art Session — Paediatric Transplantation: Challenges and Potential Solutions||Biomarkers for PTLD Diagnosis and Therapies||N-102|
09:45 - 10:45
|Oral Abstract Session — Complications Infections & Malignancies||Prospective Analysis of EBV+ PTLD in a Multi-Center Study of Pediatric Transplant Recipients||N-117/118|